The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence
The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence
复制标题
DOI:
10.1097/hjh.0000000000001110
复制
发表时间:
2016-12-01
影响因子:
4.9
通讯作者:
Schmieder, Roland E.
中科院分区:
文献类型:
--
作者:
Ott, Christian;Mahfoud, Felix;Schmieder, Roland E.
Objectives: Data on the blood pressure (BP)-lowering effect of renal denervation (RDN) in moderate treatment-resistant hypertension (TRH) are limited. Moreover, change of adherence to medication, as one potential confounder of BP response, has never been analyzed rigorously in this group of patients. W (e) analyzed the effect of RDN on BP in patients with moderate TRH who were retrospectively found to be completely adherent to their antihypertensive medication.Methods: Our study cohort comprised 40 patients with moderate TRH [office BP >= 140/90 but = 130/80 mmHg] who underwent catheter-based RDN. Further major inclusion criterion was complete adherence to their medication (>= 80% intake of their prescribed antihypertensive drugs) at baseline (assessed by retrospective toxicological analysis).Results: Six months after RDN, office BP was reduced by -10/- 6mmHg (SBP: 149 +/- 6 vs. 139 +/- 15 mmHg; DBP: 81 +/- 12 vs. 75 +/- 10 mmHg; both P < 0.001) and 24-h ABPM by -7/-4mmHg (SBP: 150 +/- 14 vs. 143 +/- 16 mmHg, P = 0.005; DBP: 82 +/- 10 vs. 78 +/- 9 mmHg, P = 0.009). Number of prescribed antihypertensive medication [6.0 (5.0-6.0) vs. 5.5 (5.0-6.0), P = 0.013] and adherence rate (95.2 +/- 7.6 vs. 91.7 +/- 13.9%, P = 0.065) was slightly reduced 6 months after RDN, both likely to underestimate the true BP reduction.Conclusion: Thus, our data indicate that even after given full respect to drug adherence as potential confounder of BP response after RDN, both office and 24-h ABPM were substantially reduced in patients with moderate TRH.